[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@WallStSai Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::90807052.png) @WallStSai S A I ™️

S A I ™️ posts on X about $xbi, $bmy, $mdgl, pfe the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.

### Engagements: XXXXXX [#](/creator/twitter::90807052/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::90807052/c:line/m:interactions.svg)

- X Week XXXXXX +21%
- X Month XXXXXXX +24%
- X Months XXXXXXXXX +347%
- X Year XXXXXXXXX +270%

### Mentions: XX [#](/creator/twitter::90807052/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::90807052/c:line/m:posts_active.svg)

- X Month XXX -XX%
- X Months XXX +245%
- X Year XXX +149%

### Followers: XXXXX [#](/creator/twitter::90807052/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::90807052/c:line/m:followers.svg)

- X Week XXXXX +0.34%
- X Month XXXXX +1.30%
- X Months XXXXX +8.40%
- X Year XXXXX +12%

### CreatorRank: XXXXXXX [#](/creator/twitter::90807052/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::90807052/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::90807052/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [finance](/list/finance)  XXXX% [currencies](/list/currencies)  #981 [countries](/list/countries)  XXXX%

**Social topic influence**
[$xbi](/topic/$xbi) #1, [$bmy](/topic/$bmy) #2, [$mdgl](/topic/$mdgl) #2, [pfe](/topic/pfe) 7.91%, [$pfe](/topic/$pfe) 7.91%, [$mrk](/topic/$mrk) #5, [$lly](/topic/$lly) 6.21%, [$gild](/topic/$gild) 5.65%, [$amgn](/topic/$amgn) 3.95%, [$nvo](/topic/$nvo) XXXX%

**Top accounts mentioned or mentioned by**
[@bioinvestor24](/creator/undefined) [@pjamess69](/creator/undefined) [@financebully](/creator/undefined) [@joserestonva](/creator/undefined) [@streetinsider](/creator/undefined) [@mroliverbarnes](/creator/undefined) [@semodough](/creator/undefined) [@drfager](/creator/undefined) [@bowtiedbiotech](/creator/undefined) [@matrixmeister](/creator/undefined) [@unusualwhales](/creator/undefined) [@snorlaxuw](/creator/undefined) [@joeyang043](/creator/undefined) [@nightowlbiotech](/creator/undefined) [@bradloncar](/creator/undefined) [@knielsen2000](/creator/undefined) [@alexsgrowth](/creator/undefined) [@stocksgoal20](/creator/undefined) [@persimmonti](/creator/undefined) [@martinshkreli](/creator/undefined)

**Top assets mentioned**
[Bitcoin Incognito (XBI)](/topic/$xbi) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Pfizer, Inc. (PFE)](/topic/$pfe) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Eli Lilly and Company (LLY)](/topic/$lly) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Amgen, Inc. (AMGN)](/topic/$amgn) [Novo-Nordisk (NVO)](/topic/$nvo) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [AstraZeneca PLC (AZN)](/topic/$azn) [AbbVie Inc (ABBV)](/topic/$abbv) [Novartis AG (NVS)](/topic/$nvs) [Synthetify (SNY)](/topic/$sny) [Johnson & Johnson (JNJ)](/topic/$jnj) [Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [TG Therapeutics, Inc. (TGTX)](/topic/$tgtx) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Humana Inc (HUM)](/topic/$hum) [Centene Corp (CNC)](/topic/$cnc) [Elevance Health Inc (ELV)](/topic/$elv) [UnitedHealth Group (UNH)](/topic/$unh) [Cigna Corp (CI)](/topic/$ci) [Intra-Cellular Therapies Inc. (ITCI)](/topic/$itci) [Akropolis (AKRO)](/topic/$akro) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Oscar Health, Inc. (OSCR)](/topic/$oscr) [Viking Holdings Ltd (VIK)](/topic/$vik) [Arcblock (ABT)](/topic/$abt) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx)
### Top Social Posts [#](/creator/twitter::90807052/posts)
---
Top posts by engagements in the last XX hours

"@bioinvestor24 $MTSR This is what I see today. XX strike puts may be added as hedge as big XX strike calls already have 5.5k as open interest"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945222407658037317) 2025-07-15 20:42:17 UTC 7060 followers, XXX engagements


"$MDGL Like said below Madrigal is very Undervalued Buyout discussions will obviously pick up pace now post Resmetirom patent extension news till 2044 ( This is huge ) I seriously budge on $BMY $PFE $MRK as strong contenders to acquire $MDGL"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945488675200016775) 2025-07-16 14:20:20 UTC 7060 followers, 1000 engagements


"Over XX% had nutritional deficiencies diagnosed within one-year of starting GLP-1RA treatment $LLY $NVO $VKTX $AMGN $XBI Glucagon-like peptide-1 receptor agonists (GLP-1RAs) drug-induced weight loss is associated with fat mass reduction but can also lead to nutritional deficiencies and loss of muscle Nutritional deficiencies were diagnosed in XXXX% of the patients within X months after GLP-1RA initiation and in XXXX% within XX months. Vitamin D deficiency was most common"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1940003389758214440) 2025-07-01 11:03:46 UTC 7060 followers, 2542 engagements


"Recent acquisitions of $BPMC ($9.5B) $VRNA ($10B) are clearly pointing $MDGL Madrigal could easily be the next M&A target for $XBI big pharma now as they rush to replace LOEs and bigger revenue holes. Madrigal may attract $12.5-$15 billion ( fully diluted shares ) in buyout premium according to current stock valuations Similar to Verona $VRNA its a single product company and obtained FDA approval for Rezdiffra in 2024. Company is currently working on MASH F4C trials. With EMA decision in August $MDGL Madrigal is expected to make $1-$1.2 billion net sales in 2026 $XBI $BMY $PFE $GILD #MASH"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942897275585401283) 2025-07-09 10:43:02 UTC 7063 followers, 3218 engagements


"$BMY BRISTOL MYERS SQUIBB SAYS PHASE X INDEPENDENCE TRIAL FOR REBLOZYL DID NOT MEET ENDPOINT"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946174604965212315) 2025-07-18 11:45:58 UTC 7060 followers, 1452 engagements


"$XBI US-SWISS TRADE DEAL LIKELY TO CONTAIN ASSURANCES ON PHARMACEUTICAL LEVY Huge Positive for Bios $XBI $NVO $NVS $RHHBY $MDGL"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1941157369091895605) 2025-07-04 15:29:16 UTC 7060 followers, 7390 engagements


"$SMMT Up XX% while the deal is still in the air. Confirmation soon from $AZN"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1943023206492967354) 2025-07-09 19:03:26 UTC 7060 followers, 1989 engagements


"$XBI Big Pharma Q2 earnings reports around the corner. Look for more M&A possibilities $GILD - 7/25 $MRK - 7/29 $AZN - 7/29 $BMY - 7/30 $ABBV - 7/31 $SNY - 7/31 $REGN - 8/1 $AMGN - 8/5 $PFE - 8/5 $NVO - 8/5 $LLY - 8/7 #biotech #mergersandacquistions"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946711214580470050) 2025-07-19 23:18:16 UTC 7060 followers, XXX engagements


"$XBI $IBB Biotech Stocks Are Ready to Rebound $MRK $PFE $ABBV $BMY $GILD $SNY"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944707014426296407) 2025-07-14 10:34:17 UTC 7060 followers, 5641 engagements


"@bioinvestor24 Big Pharma will look for candidates who can generate bigger revenues above $X billion as they have big LOE hole to fill especially $PFE $BMY $MRK"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947053475990274455) 2025-07-20 21:58:17 UTC 7060 followers, XXX engagements


"$NVS Novartis CFO on M&A + Not prioritizing Share Buybacks over Bolt-On M&A + Looking at bigger Bolt-On Deals + Have excellent BD and M&A Team + Have $XX Billion Free Cash Flow $XBI $MDGL $BBIO $TGTX $CYTK"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946170474947375193) 2025-07-18 11:29:33 UTC 7060 followers, 7762 engagements


"$BMY Bristol Myers badly needs big M&A soon to replace big LOEs revenues and I feel $MDGL is perfect fit for them $XBI I already explained why I think $BMY may acquire $MDGL below👇🏼"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1943741676373033355) 2025-07-11 18:38:23 UTC 7060 followers, 3553 engagements


"$NVS Novartis Q2 XX Core EPS: $XXXX (Est. $2.35) Net Sales: $XXXXX B (Est. $14.02B) Novartis raised its full-year core operating income forecast to low-teens growth citing strong Q2 drug sales $XBI #biotech"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945780282033844252) 2025-07-17 09:39:04 UTC 7059 followers, XXX engagements


"$BMY Big XX strike Puts bought for 6/2026 Expiration While $XBI is breaking out why such bearish bets in $BMY Bristol Myers"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1943735902359933408) 2025-07-11 18:15:26 UTC 7060 followers, XXX engagements


"$IBB Biotech ETF 8000 Calls bought for 11/21 expiration worth $X million $XBI What's brewing soon #biotech"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945666134692241646) 2025-07-17 02:05:29 UTC 7060 followers, 1520 engagements


"$BMY $PFE Bristol-Myers Squibb and Pfizer will sell Eliquis directly to patients at a discounted cash price Eliquis has a list price of $XXX for a 30-day supply but will now offer a discounted cash price of $XXX a month"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945794304242258412) 2025-07-17 10:34:47 UTC 7060 followers, XXX engagements


"@bioinvestor24 BP definitely have desperation on Obesity but I think at the same time $PFE $BMY $MRK wants Bigger revenues immediately as they lose Billions in LOEs soon. Recent Acq. $BPMC expected to make $XXX million and $VRNA expected to make $XXX million in annual sales for 2025"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947051774377922880) 2025-07-20 21:51:32 UTC 7060 followers, XXX engagements


"$AZN ASTRAZENECA TO INVEST $XX BILLION IN UNITED STATES TO EXPAND MANUFACTURING RESEARCH"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947408610805362916) 2025-07-21 21:29:28 UTC 7061 followers, 1990 engagements


"$MDGL Madrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra (Resmetirom) $XBI $PFE $BMY $GILD #MASH"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945455685220565089) 2025-07-16 12:09:14 UTC 7060 followers, 16.5K engagements


"$SMMT Up X% More Looks like a partnership announcement coming soon $AZN"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1943392019952332863) 2025-07-10 19:28:58 UTC 7060 followers, 2524 engagements


"$CNC Centene is withdrawing its previous 2025 GAAP and adjusted diluted earnings per share (EPS) guidance including the underlying guidance elements due to higher Medicaid costs $ELV $UNH $OSCR $CI $HUM $XLV"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1940153255105110171) 2025-07-01 20:59:16 UTC 7060 followers, 5057 engagements


"$MDGL Rezdiffra's market potential projecting the drug to achieve over $X billion in annual sales by 2026. Additionally the patent extends its market exclusivity up to 2044 presenting an opportunity worth $X billion in peak sales according to Piper Sandler"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945667433362051326) 2025-07-17 02:10:39 UTC 7061 followers, XXX engagements


"$BMY More Puts being added today. They should seriosuly get back to M&A deal making. Time is running out as LOE's loom and there is a good possibility of competetion for new commercial drugs $XBI"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946290249316847971) 2025-07-18 19:25:30 UTC 7060 followers, XXX engagements


"$XBI I like the last point - Pharma has big appetite for commercial stage companies Recent big commercial buyout deals $ITCI $BPMC $VRNA reflect the same fact. Next commercial stage company to get acquired is $MDGL possibly. Baker Bros back to deal making table @adamfeuerstein #Biotech"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942910643046154284) 2025-07-09 11:36:09 UTC 7058 followers, 1052 engagements


"@bioinvestor24 Does $MTSR have better data than $VKTX Stop making all time highs"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945090662799401146) 2025-07-15 11:58:46 UTC 7061 followers, XXX engagements


"$VKTX Top XX Hedge Funds holding Viking Therapeutics stock $XBI #MergersAndAcquisitions"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944425661449302110) 2025-07-13 15:56:18 UTC 7060 followers, 11.2K engagements


"$XBI The pharmaceutical industry is facing some of its steepest patent cliffs to date. $MRK $PFE $BMY $AMGN $GILD $LLY $AZN $NVS $JNJ $SNY $ABBV Drugs worth about $180bn of revenue a year are going off patent in 2027 and 2028 according to research firm Evaluate Pharma representing almost XX per cent of the global market. Big Pharma is looking for biotechs with drugs that could come on to the market soon and sell in their billions. While patent cliffs are visible years ahead investors are often not that far sighted and can be surprised when they come says Tim Opler a managing director in"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944575606416715921) 2025-07-14 01:52:07 UTC 7060 followers, 1051 engagements


"$NVO Results from a phase 1b/2a randomised controlled study: Amycretin a novel unimolecular GLP-1 and amylin receptor agonist administered subcutaneously A large number of participants withdrew from the study with a high proportion of discontinuations occurring due to reasons unrelated to treatment-emergent adverse events Source: $LLY $VKTX #GLP1 #weightloss"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1943661135447654459) 2025-07-11 13:18:20 UTC 7058 followers, 1327 engagements


"$MDGL Top XX Hedge Funds account for XXXX million common stock thats almost XX% of total outstanding XXXX million shares of Madrigal Pharma $XBI #MergersAndAcquisitions"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944424205065347327) 2025-07-13 15:50:30 UTC 7060 followers, 1839 engagements


"$MDGL Now Buyout will easily be on cards for Madrigal Pharma"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945455977781772464) 2025-07-16 12:10:24 UTC 7065 followers, 4374 engagements


"GLP-1s High Discontinuation Rate $LLY $NVO $VKTX $XBI #GLP1"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944933204051300601) 2025-07-15 01:33:05 UTC 7061 followers, 2634 engagements


"$XBI Why Patents play a key role in successful biotech M&As A most recent example where patent played a key role in $JNJ s acquisition of $ITCI On Jan10th there was a PR from $ITCI that they reached patent litigation settlement with Sandoz. The agreement allows Sandoz to sell generic CAPLYTA starting July X 2040. Thats almost XX years from now. On Jan13th there was an official PR from $JNJ regarding $ITCI takeover for $XXXX Billion It just took two non-business days to reach an M&A deal post patent settlement news. The only hiccup for $JNJ to proceed on the buyout deal was $ITCI patent $MDGL"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947428838943953259) 2025-07-21 22:49:51 UTC 7061 followers, XXX engagements


"$XBI $IBB Junes Busy Buyout Binge Bolsters M&A Stats for H1 Six deals were announced in June from BioNTechs $XXXX billion buy of mRNA rival CureVac to Eli Lillys validation of the gene editing space via the $XXX billion acquisition of Verve Therapeutics $LLY $VERV $BNTX $BMY $CVAC"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1940009775867007153) 2025-07-01 11:29:08 UTC 7058 followers, 1120 engagements


"$AKRO Are we still buying this Akero buyout rumor Stock is up XX% on just this rumor from SI. But at the same time Short Interest in Akero surged to all time highs. Very Interesting 🤨 @Street_Insider $XBI $MDGL $ETNB"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946316125966368987) 2025-07-18 21:08:19 UTC 7060 followers, 1565 engagements


"$PFE Pfizer Patents that Expire Soon Who will they buy to replace the Big revenue hole $XBI $VKTX $TGTX $BBIO $MDGL"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945301852293095510) 2025-07-16 01:57:58 UTC 7061 followers, 13.7K engagements


"$BMY Bristol Myers Squibb continues New Jersey Layoffs Bringing Yearly Total to Nearly XXX. The pharma has now cut over 1000 employees there since April 2024 as part of its cost-cutting measures. $XBI $MDGL $PFE $MRK $GILD"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1939868760665383346) 2025-07-01 02:08:48 UTC 7060 followers, XXX engagements


"$XBI $BMY Bristol Myers Squibb faces big LOE as soon as 2026 Expiration of patents on BMS drugs could result in a $XX billion topline headwind to sales by 2030 Specifically analyst consensus revenue estimates as collected by Refinitv suggest that BMYs sales will likely drop to $XX billion by 2030 down from $XXXX billion in 2024. Bristol Myers Squibb faces the impending patent expiries of Eliquis Opdivo and Pomalyst. Both Eliquis and Pomalyst are due to lose their patent protection sometime around 2026 and Opdivo is likely to lose patent protection in 2028. Cumulatively these X products"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945317311545577622) 2025-07-16 02:59:23 UTC 7060 followers, 1634 engagements


"@bradloncar Awesome Brad Great Interview and you asked him about $MRK deal to the point crystal clear Appreciate all your good work sir 🙏🏼"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1943469127701860416) 2025-07-11 00:35:22 UTC 7060 followers, XXX engagements


"$MRK MERCK WANTS TO EXPAND THROUGH BIGGER MERGERS AND ACQUISITIONS MIGHT GO BEYOND $XX BILLION $XBI #MergersAndAcquisitions"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942924492486951421) 2025-07-09 12:31:11 UTC 7060 followers, 14.7K engagements


"BIG DAY for Health Insurers tomorrow with $ELV Elevance Health reporting Q2 earnings. Watch for knee jerk reactions in $CNC $UNH $HUM $CI $ELV The consensus EPS Estimate is $XXXX and the consensus Revenue Estimate is $48.2B Health Insurer stock sentiment is at all time low"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945678373285462157) 2025-07-17 02:54:07 UTC 7060 followers, 1194 engagements


"$XBI Do we get any Biotech M&A for July4th long weekend Is the Big Pharma really ready to push the Buy button What are your most desirable or most probable candidates for acquisition #MergersAndAcquisitions $BMY $PFE $MRK $GILD $JNJ $NVS $SNY $REGN $AMGN $ABBV $ABT"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1940770406979531138) 2025-07-03 13:51:37 UTC 7060 followers, XXX engagements


"$XBI I think @bioinvestor24 you just keep touting GLP-1s forever. I respect it but please try to increase your MASH knowledge as well. $MDGL Rezdiffra has multiple advantages - Fibrosis Reversal Lower Cholesterol and Weight Loss I have seen many patient feedbacks regarding losing good amount of weight with Rezdiffra and how effective the drug was treating their MASH condition and reversing Fibrosis. You always talk about high cost of the drug but you need to remember company has put in great efforts to get the first and only approved MASH drug into the market they didnt invent the drug"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942542053361041837) 2025-07-08 11:11:30 UTC 7060 followers, 2444 engagements


"$AKRO Akeros Compensated Cirrhosis (F4) Ph3 data due Late 2029 whereas $MDGL Madrigals F4 Ph3 final readout due Jan 2027 $AKRO Currently makes no revenues and would take atleast X years from now to commercialize its F4 product if approved by FDA $MDGL Madrigal currently expected to make $XXX Million net sales for 2025 and sales could increase if it obtains EMA approval in August 2025 When you compare both $MDGL Madrigal is clearly a Winner as its already generating revenues and expanding globally at rapid pace. By early 2027 it would apply for Label Expansion and use Rezdiffra for F4"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1931722275918614581) 2025-06-08 14:37:34 UTC 7061 followers, 4123 engagements


"$VRNA There has been significant amount of insider selling just before Verona Pharma has been bought out by $MRK Merck on 7/9 $XBI There is a common misconception on social media - If insiders are selling company is not ready to sell. Technically there is no relationship between insiders selling and company being bought out. Most these insider sells are part of pre aggregated 10b5-1 trading plan adopted by Insiders. Rule 10b5-1 is a Securities and Exchange Commission (SEC) regulation that allows insiders of public companies to set up a trading plan for selling stocks they own. Rule 10b5-1"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947016218143068472) 2025-07-20 19:30:14 UTC 7060 followers, 5940 engagements


"@yaireinhorn @Merck $BMY loses big from LOE and definitely need to look for big acquisitions now. Feel free to go through below post on my M&A prediction $BMY $MDGL"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947457824227004851) 2025-07-22 00:45:01 UTC 7061 followers, XXX engagements


"CHINESE BIOTECH SCIWIND BIOSCIENCES SHOWCASES CHALLENGER TO $LLY ELI LILLYS OBESITY DRUG Once approved Sciwinds ecnoglutide will compete with Novos Wegovy and Eli Lillys Zepbound as well as Innovent Biologics Inc in the China market $NVO $VKTX $XBI #GLP1"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1936933504345894921) 2025-06-22 23:45:08 UTC 7060 followers, 5166 engagements


"$ABBV AbbVie Unit Wins $XX Million from Revance Over Botox Patents Revance's anti-wrinkle medication Daxxify infringed patents covering Allergan's rival drug Botox"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947416196137017633) 2025-07-21 21:59:37 UTC 7060 followers, XXX engagements


"@bioinvestor24 Do you think $MRK is still interested in $MLTX Its market cap is already $3.4B now"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947418959084397049) 2025-07-21 22:10:35 UTC 7061 followers, XXX engagements


"$MDGL Rezdiffras peak revenues $4B. But stock trading only $6.3B which makes it very undervalued not even trading 2x peak sales. Madrigal would be a good strategic commercial stage fit for Big Pharma at this cheap valuation @semodough $XBI $BMY $PFE $GILD $AMGN $LLY"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942913074287005819) 2025-07-09 11:45:49 UTC 7060 followers, 2558 engagements


"@KNielsen2000 @bioinvestor24 @Street_Insider That really doesnt matter as there are many patient support options available now a days as they get to access drug for as low as $XX per month. So no big deal on pricing according to me"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946323045078937603) 2025-07-18 21:35:49 UTC 7061 followers, XX engagements


"$XBI That is why we are seeing more M&A deals this year in biotech space Big Pharma started acting swiftly on BD. We should see more bigger size deals as amount of revenue hole is big enough to fill for $PFE $BMY $MRK $AMGN $GILD $SNY $AZN $ABBV $LLY $JNJ"  
![@WallStSai Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::90807052.png) [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947365521201995941) 2025-07-21 18:38:15 UTC 7060 followers, 10.7K engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@WallStSai S A I ™️

S A I ™️ posts on X about $xbi, $bmy, $mdgl, pfe the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

X Week XXXXXX +21%
X Month XXXXXXX +24%
X Months XXXXXXXXX +347%
X Year XXXXXXXXX +270%

Mentions: XX #

X Month XXX -XX%
X Months XXX +245%
X Year XXX +149%

Followers: XXXXX #

X Week XXXXX +0.34%
X Month XXXXX +1.30%
X Months XXXXX +8.40%
X Year XXXXX +12%

CreatorRank: XXXXXXX #

Social Influence #

Social category influence stocks XXXXX% finance XXXX% currencies #981 countries XXXX%

Social topic influence $xbi #1, $bmy #2, $mdgl #2, pfe 7.91%, $pfe 7.91%, $mrk #5, $lly 6.21%, $gild 5.65%, $amgn 3.95%, $nvo XXXX%

Top accounts mentioned or mentioned by @bioinvestor24 @pjamess69 @financebully @joserestonva @streetinsider @mroliverbarnes @semodough @drfager @bowtiedbiotech @matrixmeister @unusualwhales @snorlaxuw @joeyang043 @nightowlbiotech @bradloncar @knielsen2000 @alexsgrowth @stocksgoal20 @persimmonti @martinshkreli

Top assets mentioned Bitcoin Incognito (XBI) Bristol-Myers Squibb Co (BMY) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Pfizer, Inc. (PFE) Merck & Co., Inc. (MRK) Eli Lilly and Company (LLY) Gilead Sciences, Inc. (GILD) Amgen, Inc. (AMGN) Novo-Nordisk (NVO) Viking Therapeutics, Inc (VKTX) AstraZeneca PLC (AZN) AbbVie Inc (ABBV) Novartis AG (NVS) Synthetify (SNY) Johnson & Johnson (JNJ) Blueprint Medicines Corporation (BPMC) Summit Therapeutics Inc. Common Stock (SMMT) BridgeBio Pharma, Inc. Common Stock (BBIO) TG Therapeutics, Inc. (TGTX) Metsera, Inc. Common Stock (MTSR) Regeneron Pharmaceuticals Inc (REGN) Humana Inc (HUM) Centene Corp (CNC) Elevance Health Inc (ELV) UnitedHealth Group (UNH) Cigna Corp (CI) Intra-Cellular Therapies Inc. (ITCI) Akropolis (AKRO) Cytokinetics Inc. (CYTK) Oscar Health, Inc. (OSCR) Viking Holdings Ltd (VIK) Arcblock (ABT) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)

Top Social Posts #

Top posts by engagements in the last XX hours

"@bioinvestor24 $MTSR This is what I see today. XX strike puts may be added as hedge as big XX strike calls already have 5.5k as open interest"
@WallStSai on X 2025-07-15 20:42:17 UTC 7060 followers, XXX engagements

"$MDGL Like said below Madrigal is very Undervalued Buyout discussions will obviously pick up pace now post Resmetirom patent extension news till 2044 ( This is huge ) I seriously budge on $BMY $PFE $MRK as strong contenders to acquire $MDGL"
@WallStSai on X 2025-07-16 14:20:20 UTC 7060 followers, 1000 engagements

"Over XX% had nutritional deficiencies diagnosed within one-year of starting GLP-1RA treatment $LLY $NVO $VKTX $AMGN $XBI Glucagon-like peptide-1 receptor agonists (GLP-1RAs) drug-induced weight loss is associated with fat mass reduction but can also lead to nutritional deficiencies and loss of muscle Nutritional deficiencies were diagnosed in XXXX% of the patients within X months after GLP-1RA initiation and in XXXX% within XX months. Vitamin D deficiency was most common"
@WallStSai on X 2025-07-01 11:03:46 UTC 7060 followers, 2542 engagements

"Recent acquisitions of $BPMC ($9.5B) $VRNA ($10B) are clearly pointing $MDGL Madrigal could easily be the next M&A target for $XBI big pharma now as they rush to replace LOEs and bigger revenue holes. Madrigal may attract $12.5-$15 billion ( fully diluted shares ) in buyout premium according to current stock valuations Similar to Verona $VRNA its a single product company and obtained FDA approval for Rezdiffra in 2024. Company is currently working on MASH F4C trials. With EMA decision in August $MDGL Madrigal is expected to make $1-$1.2 billion net sales in 2026 $XBI $BMY $PFE $GILD #MASH"
@WallStSai on X 2025-07-09 10:43:02 UTC 7063 followers, 3218 engagements

"$BMY BRISTOL MYERS SQUIBB SAYS PHASE X INDEPENDENCE TRIAL FOR REBLOZYL DID NOT MEET ENDPOINT"
@WallStSai on X 2025-07-18 11:45:58 UTC 7060 followers, 1452 engagements

"$XBI US-SWISS TRADE DEAL LIKELY TO CONTAIN ASSURANCES ON PHARMACEUTICAL LEVY Huge Positive for Bios $XBI $NVO $NVS $RHHBY $MDGL"
@WallStSai on X 2025-07-04 15:29:16 UTC 7060 followers, 7390 engagements

"$SMMT Up XX% while the deal is still in the air. Confirmation soon from $AZN"
@WallStSai on X 2025-07-09 19:03:26 UTC 7060 followers, 1989 engagements

"$XBI Big Pharma Q2 earnings reports around the corner. Look for more M&A possibilities $GILD - 7/25 $MRK - 7/29 $AZN - 7/29 $BMY - 7/30 $ABBV - 7/31 $SNY - 7/31 $REGN - 8/1 $AMGN - 8/5 $PFE - 8/5 $NVO - 8/5 $LLY - 8/7 #biotech #mergersandacquistions"
@WallStSai on X 2025-07-19 23:18:16 UTC 7060 followers, XXX engagements

"$XBI $IBB Biotech Stocks Are Ready to Rebound $MRK $PFE $ABBV $BMY $GILD $SNY"
@WallStSai on X 2025-07-14 10:34:17 UTC 7060 followers, 5641 engagements

"@bioinvestor24 Big Pharma will look for candidates who can generate bigger revenues above $X billion as they have big LOE hole to fill especially $PFE $BMY $MRK"
@WallStSai on X 2025-07-20 21:58:17 UTC 7060 followers, XXX engagements

"$NVS Novartis CFO on M&A + Not prioritizing Share Buybacks over Bolt-On M&A + Looking at bigger Bolt-On Deals + Have excellent BD and M&A Team + Have $XX Billion Free Cash Flow $XBI $MDGL $BBIO $TGTX $CYTK"
@WallStSai on X 2025-07-18 11:29:33 UTC 7060 followers, 7762 engagements

"$BMY Bristol Myers badly needs big M&A soon to replace big LOEs revenues and I feel $MDGL is perfect fit for them $XBI I already explained why I think $BMY may acquire $MDGL below👇🏼"
@WallStSai on X 2025-07-11 18:38:23 UTC 7060 followers, 3553 engagements

"$NVS Novartis Q2 XX Core EPS: $XXXX (Est. $2.35) Net Sales: $XXXXX B (Est. $14.02B) Novartis raised its full-year core operating income forecast to low-teens growth citing strong Q2 drug sales $XBI #biotech"
@WallStSai on X 2025-07-17 09:39:04 UTC 7059 followers, XXX engagements

"$BMY Big XX strike Puts bought for 6/2026 Expiration While $XBI is breaking out why such bearish bets in $BMY Bristol Myers"
@WallStSai on X 2025-07-11 18:15:26 UTC 7060 followers, XXX engagements

"$IBB Biotech ETF 8000 Calls bought for 11/21 expiration worth $X million $XBI What's brewing soon #biotech"
@WallStSai on X 2025-07-17 02:05:29 UTC 7060 followers, 1520 engagements

"$BMY $PFE Bristol-Myers Squibb and Pfizer will sell Eliquis directly to patients at a discounted cash price Eliquis has a list price of $XXX for a 30-day supply but will now offer a discounted cash price of $XXX a month"
@WallStSai on X 2025-07-17 10:34:47 UTC 7060 followers, XXX engagements

"@bioinvestor24 BP definitely have desperation on Obesity but I think at the same time $PFE $BMY $MRK wants Bigger revenues immediately as they lose Billions in LOEs soon. Recent Acq. $BPMC expected to make $XXX million and $VRNA expected to make $XXX million in annual sales for 2025"
@WallStSai on X 2025-07-20 21:51:32 UTC 7060 followers, XXX engagements

"$AZN ASTRAZENECA TO INVEST $XX BILLION IN UNITED STATES TO EXPAND MANUFACTURING RESEARCH"
@WallStSai on X 2025-07-21 21:29:28 UTC 7061 followers, 1990 engagements

"$MDGL Madrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra (Resmetirom) $XBI $PFE $BMY $GILD #MASH"
@WallStSai on X 2025-07-16 12:09:14 UTC 7060 followers, 16.5K engagements

"$SMMT Up X% More Looks like a partnership announcement coming soon $AZN"
@WallStSai on X 2025-07-10 19:28:58 UTC 7060 followers, 2524 engagements

"$CNC Centene is withdrawing its previous 2025 GAAP and adjusted diluted earnings per share (EPS) guidance including the underlying guidance elements due to higher Medicaid costs $ELV $UNH $OSCR $CI $HUM $XLV"
@WallStSai on X 2025-07-01 20:59:16 UTC 7060 followers, 5057 engagements

"$MDGL Rezdiffra's market potential projecting the drug to achieve over $X billion in annual sales by 2026. Additionally the patent extends its market exclusivity up to 2044 presenting an opportunity worth $X billion in peak sales according to Piper Sandler"
@WallStSai on X 2025-07-17 02:10:39 UTC 7061 followers, XXX engagements

"$BMY More Puts being added today. They should seriosuly get back to M&A deal making. Time is running out as LOE's loom and there is a good possibility of competetion for new commercial drugs $XBI"
@WallStSai on X 2025-07-18 19:25:30 UTC 7060 followers, XXX engagements

"$XBI I like the last point - Pharma has big appetite for commercial stage companies Recent big commercial buyout deals $ITCI $BPMC $VRNA reflect the same fact. Next commercial stage company to get acquired is $MDGL possibly. Baker Bros back to deal making table @adamfeuerstein #Biotech"
@WallStSai on X 2025-07-09 11:36:09 UTC 7058 followers, 1052 engagements

"@bioinvestor24 Does $MTSR have better data than $VKTX Stop making all time highs"
@WallStSai on X 2025-07-15 11:58:46 UTC 7061 followers, XXX engagements

"$VKTX Top XX Hedge Funds holding Viking Therapeutics stock $XBI #MergersAndAcquisitions"
@WallStSai on X 2025-07-13 15:56:18 UTC 7060 followers, 11.2K engagements

"$XBI The pharmaceutical industry is facing some of its steepest patent cliffs to date. $MRK $PFE $BMY $AMGN $GILD $LLY $AZN $NVS $JNJ $SNY $ABBV Drugs worth about $180bn of revenue a year are going off patent in 2027 and 2028 according to research firm Evaluate Pharma representing almost XX per cent of the global market. Big Pharma is looking for biotechs with drugs that could come on to the market soon and sell in their billions. While patent cliffs are visible years ahead investors are often not that far sighted and can be surprised when they come says Tim Opler a managing director in"
@WallStSai on X 2025-07-14 01:52:07 UTC 7060 followers, 1051 engagements

"$NVO Results from a phase 1b/2a randomised controlled study: Amycretin a novel unimolecular GLP-1 and amylin receptor agonist administered subcutaneously A large number of participants withdrew from the study with a high proportion of discontinuations occurring due to reasons unrelated to treatment-emergent adverse events Source: $LLY $VKTX #GLP1 #weightloss"
@WallStSai on X 2025-07-11 13:18:20 UTC 7058 followers, 1327 engagements

"$MDGL Top XX Hedge Funds account for XXXX million common stock thats almost XX% of total outstanding XXXX million shares of Madrigal Pharma $XBI #MergersAndAcquisitions"
@WallStSai on X 2025-07-13 15:50:30 UTC 7060 followers, 1839 engagements

"$MDGL Now Buyout will easily be on cards for Madrigal Pharma"
@WallStSai on X 2025-07-16 12:10:24 UTC 7065 followers, 4374 engagements

"GLP-1s High Discontinuation Rate $LLY $NVO $VKTX $XBI #GLP1"
@WallStSai on X 2025-07-15 01:33:05 UTC 7061 followers, 2634 engagements

"$XBI Why Patents play a key role in successful biotech M&As A most recent example where patent played a key role in $JNJ s acquisition of $ITCI On Jan10th there was a PR from $ITCI that they reached patent litigation settlement with Sandoz. The agreement allows Sandoz to sell generic CAPLYTA starting July X 2040. Thats almost XX years from now. On Jan13th there was an official PR from $JNJ regarding $ITCI takeover for $XXXX Billion It just took two non-business days to reach an M&A deal post patent settlement news. The only hiccup for $JNJ to proceed on the buyout deal was $ITCI patent $MDGL"
@WallStSai on X 2025-07-21 22:49:51 UTC 7061 followers, XXX engagements

"$XBI $IBB Junes Busy Buyout Binge Bolsters M&A Stats for H1 Six deals were announced in June from BioNTechs $XXXX billion buy of mRNA rival CureVac to Eli Lillys validation of the gene editing space via the $XXX billion acquisition of Verve Therapeutics $LLY $VERV $BNTX $BMY $CVAC"
@WallStSai on X 2025-07-01 11:29:08 UTC 7058 followers, 1120 engagements

"$AKRO Are we still buying this Akero buyout rumor Stock is up XX% on just this rumor from SI. But at the same time Short Interest in Akero surged to all time highs. Very Interesting 🤨 @Street_Insider $XBI $MDGL $ETNB"
@WallStSai on X 2025-07-18 21:08:19 UTC 7060 followers, 1565 engagements

"$PFE Pfizer Patents that Expire Soon Who will they buy to replace the Big revenue hole $XBI $VKTX $TGTX $BBIO $MDGL"
@WallStSai on X 2025-07-16 01:57:58 UTC 7061 followers, 13.7K engagements

"$BMY Bristol Myers Squibb continues New Jersey Layoffs Bringing Yearly Total to Nearly XXX. The pharma has now cut over 1000 employees there since April 2024 as part of its cost-cutting measures. $XBI $MDGL $PFE $MRK $GILD"
@WallStSai on X 2025-07-01 02:08:48 UTC 7060 followers, XXX engagements

"$XBI $BMY Bristol Myers Squibb faces big LOE as soon as 2026 Expiration of patents on BMS drugs could result in a $XX billion topline headwind to sales by 2030 Specifically analyst consensus revenue estimates as collected by Refinitv suggest that BMYs sales will likely drop to $XX billion by 2030 down from $XXXX billion in 2024. Bristol Myers Squibb faces the impending patent expiries of Eliquis Opdivo and Pomalyst. Both Eliquis and Pomalyst are due to lose their patent protection sometime around 2026 and Opdivo is likely to lose patent protection in 2028. Cumulatively these X products"
@WallStSai on X 2025-07-16 02:59:23 UTC 7060 followers, 1634 engagements

"@bradloncar Awesome Brad Great Interview and you asked him about $MRK deal to the point crystal clear Appreciate all your good work sir 🙏🏼"
@WallStSai on X 2025-07-11 00:35:22 UTC 7060 followers, XXX engagements

"$MRK MERCK WANTS TO EXPAND THROUGH BIGGER MERGERS AND ACQUISITIONS MIGHT GO BEYOND $XX BILLION $XBI #MergersAndAcquisitions"
@WallStSai on X 2025-07-09 12:31:11 UTC 7060 followers, 14.7K engagements

"BIG DAY for Health Insurers tomorrow with $ELV Elevance Health reporting Q2 earnings. Watch for knee jerk reactions in $CNC $UNH $HUM $CI $ELV The consensus EPS Estimate is $XXXX and the consensus Revenue Estimate is $48.2B Health Insurer stock sentiment is at all time low"
@WallStSai on X 2025-07-17 02:54:07 UTC 7060 followers, 1194 engagements

"$XBI Do we get any Biotech M&A for July4th long weekend Is the Big Pharma really ready to push the Buy button What are your most desirable or most probable candidates for acquisition #MergersAndAcquisitions $BMY $PFE $MRK $GILD $JNJ $NVS $SNY $REGN $AMGN $ABBV $ABT"
@WallStSai on X 2025-07-03 13:51:37 UTC 7060 followers, XXX engagements

"$XBI I think @bioinvestor24 you just keep touting GLP-1s forever. I respect it but please try to increase your MASH knowledge as well. $MDGL Rezdiffra has multiple advantages - Fibrosis Reversal Lower Cholesterol and Weight Loss I have seen many patient feedbacks regarding losing good amount of weight with Rezdiffra and how effective the drug was treating their MASH condition and reversing Fibrosis. You always talk about high cost of the drug but you need to remember company has put in great efforts to get the first and only approved MASH drug into the market they didnt invent the drug"
@WallStSai on X 2025-07-08 11:11:30 UTC 7060 followers, 2444 engagements

"$AKRO Akeros Compensated Cirrhosis (F4) Ph3 data due Late 2029 whereas $MDGL Madrigals F4 Ph3 final readout due Jan 2027 $AKRO Currently makes no revenues and would take atleast X years from now to commercialize its F4 product if approved by FDA $MDGL Madrigal currently expected to make $XXX Million net sales for 2025 and sales could increase if it obtains EMA approval in August 2025 When you compare both $MDGL Madrigal is clearly a Winner as its already generating revenues and expanding globally at rapid pace. By early 2027 it would apply for Label Expansion and use Rezdiffra for F4"
@WallStSai on X 2025-06-08 14:37:34 UTC 7061 followers, 4123 engagements

"$VRNA There has been significant amount of insider selling just before Verona Pharma has been bought out by $MRK Merck on 7/9 $XBI There is a common misconception on social media - If insiders are selling company is not ready to sell. Technically there is no relationship between insiders selling and company being bought out. Most these insider sells are part of pre aggregated 10b5-1 trading plan adopted by Insiders. Rule 10b5-1 is a Securities and Exchange Commission (SEC) regulation that allows insiders of public companies to set up a trading plan for selling stocks they own. Rule 10b5-1"
@WallStSai on X 2025-07-20 19:30:14 UTC 7060 followers, 5940 engagements

"@yaireinhorn @Merck $BMY loses big from LOE and definitely need to look for big acquisitions now. Feel free to go through below post on my M&A prediction $BMY $MDGL"
@WallStSai on X 2025-07-22 00:45:01 UTC 7061 followers, XXX engagements

"CHINESE BIOTECH SCIWIND BIOSCIENCES SHOWCASES CHALLENGER TO $LLY ELI LILLYS OBESITY DRUG Once approved Sciwinds ecnoglutide will compete with Novos Wegovy and Eli Lillys Zepbound as well as Innovent Biologics Inc in the China market $NVO $VKTX $XBI #GLP1"
@WallStSai on X 2025-06-22 23:45:08 UTC 7060 followers, 5166 engagements

"$ABBV AbbVie Unit Wins $XX Million from Revance Over Botox Patents Revance's anti-wrinkle medication Daxxify infringed patents covering Allergan's rival drug Botox"
@WallStSai on X 2025-07-21 21:59:37 UTC 7060 followers, XXX engagements

"@bioinvestor24 Do you think $MRK is still interested in $MLTX Its market cap is already $3.4B now"
@WallStSai on X 2025-07-21 22:10:35 UTC 7061 followers, XXX engagements

"$MDGL Rezdiffras peak revenues $4B. But stock trading only $6.3B which makes it very undervalued not even trading 2x peak sales. Madrigal would be a good strategic commercial stage fit for Big Pharma at this cheap valuation @semodough $XBI $BMY $PFE $GILD $AMGN $LLY"
@WallStSai on X 2025-07-09 11:45:49 UTC 7060 followers, 2558 engagements

"@KNielsen2000 @bioinvestor24 @Street_Insider That really doesnt matter as there are many patient support options available now a days as they get to access drug for as low as $XX per month. So no big deal on pricing according to me"
@WallStSai on X 2025-07-18 21:35:49 UTC 7061 followers, XX engagements

"$XBI That is why we are seeing more M&A deals this year in biotech space Big Pharma started acting swiftly on BD. We should see more bigger size deals as amount of revenue hole is big enough to fill for $PFE $BMY $MRK $AMGN $GILD $SNY $AZN $ABBV $LLY $JNJ"
@WallStSai on X 2025-07-21 18:38:15 UTC 7060 followers, 10.7K engagements